04/25/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
8:30 AM | Can-Fite BioPharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
|
03/28/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:27 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
6:06 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:32 PM | ARMISTICE CAPITAL, LLC (Filed by)
Can-Fite BioPharma (Subject)
| Form SC 13G | |
01/30/2024
6:24 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
12/28/2023
3:16 PM | Can-Fite BioPharma (Filer)
| Form F-3/A | |
12/20/2023
6:09 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/04/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/30/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:20 PM | Can-Fite BioPharma (Filer)
| Form 424B3 | |
11/21/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023
6:11 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023
6:01 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/10/2023
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/07/2023
6:25 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
09/01/2023
3:16 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
08/31/2023
6:12 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/24/2023
6:19 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2023
6:06 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2023
6:11 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
6:10 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2023
6:08 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
06/01/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023
6:14 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
6:08 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
